Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcbest (ARCB) Asset Writedowns and Impairment (2016 - 2025)

Historic Asset Writedowns and Impairment for Arcbest (ARCB) over the last 17 years, with Q3 2025 value amounting to $984000.0.

  • Arcbest's Asset Writedowns and Impairment rose 2455.7% to $984000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 million, marking a year-over-year increase of 15910.0%. This contributed to the annual value of $4.8 million for FY2024, which is 8397.32% down from last year.
  • As of Q3 2025, Arcbest's Asset Writedowns and Impairment stood at $984000.0, which was up 2455.7% from $273000.0 recorded in Q2 2025.
  • Over the past 5 years, Arcbest's Asset Writedowns and Impairment peaked at $30.2 million during Q3 2023, and registered a low of -$238000.0 during Q2 2021.
  • For the 5-year period, Arcbest's Asset Writedowns and Impairment averaged around $2.5 million, with its median value being $1.1 million (2024).
  • Its Asset Writedowns and Impairment has fluctuated over the past 5 years, first plummeted by 10694.14% in 2021, then surged by 745789.47% in 2024.
  • Arcbest's Asset Writedowns and Impairment (Quarter) stood at $1.5 million in 2021, then rose by 24.1% to $1.9 million in 2022, then tumbled by 102.01% to -$38000.0 in 2023, then surged by 7457.89% to $2.8 million in 2024, then crashed by 64.81% to $984000.0 in 2025.
  • Its last three reported values are $984000.0 in Q3 2025, $273000.0 for Q2 2025, and $1.1 million during Q1 2025.